Table of Contents

HK J Paediatr (New Series)
Vol 5. No. 1, 2000

HK J Paediatr (New Series) 2000;5:86

Proceedings of 2nd Hong Kong Medical Genetics Conference

Human Genome Project: Progress and Prospect

EY Chen


HK J Paediatr (new series) 2000;5:85-89

Proceedings of 2nd Hong Kong Medical Genetics Conference, Hong Kong Society of Medical Genetics (Selected Abstracts)
15-17 October, 1999

Improvement of automated sequencing technology has made tremendous progress in recent years, particularly in the areas of throughput capacity, data quality and operational reliability. As a result, by mid-1999 the international efforts in large-scale sequencing has completed several projects; including about 20 bacterial genomes (those <5 Mb's), yeast (12 Mb), nematode (C. elegans, 97 Mb), 35% of Arabidopsis (~100 Mb), and approximately 400 megabases or 13% of human (~3,000 Mb). Interestingly a major portion of these data (~80%) was elucidated only within the last couple years, indicating a trend that the automated sequencing efficiency has just entered an exponentially growing stage. With that trend continues, the latest released capillary-based equipment can increase the sequencing efficiency by at least 5 folds. Combined with the advanced data management and processing systems, it is increasingly possible that the human genome can be sequenced by 2001 through the efforts involving both public and commercial organizations.

During 1998, commercial company joined the race to sequence the human genome. Founded in May, 1998, Celera Genomics plans to sequence Drosophila, human, rice and mouse genomes starting in the middle of 1999 using whole genome shotgun sequencing strategy. It will likely yield additional novel and rarely expressed genes, as well as millions of polymorphism information. The company is adopting a policy to make its Drosophila and human sequence data available to the research community for free.

With the participation of commercial organizations in genomic sequencing, the annual investment for that activity is now reaching >$400 million US dollars. The combined total throughput is estimated to be >600 Mb/year for 1999, and it will likely continue to grow in the subsequent years. Many large genomes will be sequenced during early 21st century. Thus, with enormous volume of genomic sequence information becoming available, the challenge is shifting towards the downstream sequence interpretation and functional investigations in the modern era of genomes in biological research.

 
 

This web site is sponsored by Johnson & Johnson (HK) Ltd.
©2021 Hong Kong Journal of Paediatrics. All rights reserved. Developed and maintained by Medcom Ltd.